When did Jubiliant Life Sciences got USFDA approval for selling its generic drugs in the US market?
Others answers (1)
- eAnswers...Jan 28, 2015
Jubilant Life Sciences got USFDA approval for selling its generic drugs in the US market on January 5, 2015. Mycophenolate Mofetil is used for treatment of migraine, are generics of Merck's Maxalt tablets. These capsules are manufactured by the company's US army Jubilant Cadista Pharmaceuticals, Inc and Rizatriptan tablets are made at Jubilant Generics Ltd, Jubilant Life Sciences.
- RelationshipsMay 14, 2014
- 16 Acts Of Random Kindness That Will Revive Your Hope For The Future Of Mankind
- Show More